https://www.zacks.com/stock/news/2250719/amarin-amrn-up-7-on-intellectual-property-wins-in-europe?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2250719
Apr 04, 2024 - Amarin (AMRN) secures a new patent for Vazkepa in Europe, which extends its exclusivity for eight more years. It achieves success in defending another patent on the drug against third parties.
zc:1537663244607216
0
https://www.zacks.com/stock/news/2250716/koppers-kop-wraps-up-acquisition-of-brown-wood-preserving?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2250716
Apr 04, 2024 - Koppers (KOP) closes the Brown Wood acquisition, eyeing market expansion and synergy-driven growth in utility poles, with substantial EBITDA expected by 2025.
zc:5173765108747345165
0
https://www.zacks.com/stock/news/2250684/advanced-drainage-systems-wms-is-up-0-58-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2250684
Apr 04, 2024 - Does Advanced Drainage Systems (WMS) have what it takes to be a top stock pick for momentum investors? Let's find out.
zc:4271727978365720001
0
https://www.zacks.com/stock/news/2250632/blackberry-bb-q4-earnings-beat-estimates-revenues-up-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-2250632
Apr 04, 2024 - BlackBerry's (BB) fiscal fourth-quarter performance benefits from solid momentum across Cybersecurity and IoT business units.
zc:3365775740313800652
0
https://www.zacks.com/stock/news/2250526/genprex-gnpx-expands-sclc-study-of-key-candidate-stock-up?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2250526
Apr 04, 2024 - Genprex (GNPX) gains 9.5% after expanding clinical study sites in the United States for the early to mid-stage study of lead candidate, Reqorsa, to treat lung cancer patients.
zc:8803092640589756350
0
https://seekingalpha.com/article/4682031-ulta-beauty-inc-ulta-jpmorgan-10th-annual-retail-round-up-conference-transcript?source=feed_sector_transcripts
Apr 03, 2024 - Ulta Beauty, Inc. (NASDAQ:NASDAQ:ULTA) JPMorgan 10th Annual Retail Round Up Conference April 3, 2024 9:00 AM ETCompany ParticipantsDavid Kimbell - Chief...
0
sa:-3817521394211341240
0
https://www.zacks.com/stock/news/2249999/manulife-mfc-shares-up-11-ytd-more-room-for-upside?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2249999
Apr 03, 2024 - Manulife (MFC) appears well-poised for growth on its strengthening Asia business, expanding Wealth and Asset Management business, cost savings to improve profitability and solid capital position.
zc:3528573799276864810
0
https://www.zacks.com/stock/news/2249959/vanda-vnda-up-on-fda-nod-for-fanapt-in-bipolar-i-disorder?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2249959
Apr 03, 2024 - Vanda (VNDA) announces the FDA's approval of Fanapt for the acute treatment of bipolar I disorder in adults. The stock rises 30.4%.
zc:-8253803401341297518
0
https://www.zacks.com/stock/news/2249972/msa-safety-msa-is-up-3-26-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2249972
Apr 03, 2024 - Does MSA Safety (MSA) have what it takes to be a top stock pick for momentum investors? Let's find out.
zc:1565135576607628017
0
https://www.zacks.com/stock/news/2249977/pagseguro-digital-ltd-pags-is-up-2-44-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2249977
Apr 03, 2024 - Does PagSeguro Digital Ltd. (PAGS) have what it takes to be a top stock pick for momentum investors? Let's find out.
zc:2647745652445645788
0